AARON KANTOFF - 28 Mar 2024 Form 3 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Donald R. Reynolds by power of attorney
Issuer symbol
AVTX
Transactions as of
28 Mar 2024
Net transactions value
$0
Form type
3
Filing time
03 Apr 2024, 16:01:16 UTC
Previous filing
26 Oct 2023
Next filing
07 Jun 2024

No securities are beneficially owned.